ABSTRACT
This study aimed to summarize the diagnosis and treatment of uncommon complications in esophageal and cardiac cancer operations as well as obtain lessons from the failure. Methods:The etiology, clinical diagnosis, treatment, prevention measures, and factors that contribute to the failure of the uncommon complications were analyzed retrospectively. Results: Results showed ten cured cases and eight death cases (except for the reported eight cases). Conclusion:The following conclusions were ob-tained. 1) The complications described in this paper were rare, but they sometimes occur clinically. If wrong treatment was taken, seri-ous consequences would be expected. 2) Once a jet-like bleeding of aortic esophagus avulsion injury occurs, the surgeon must be calm and take proper treatment to successfully patch up the wounds. 3) The right thoracic approach is a new approach to prevent the injury of azygos vein. 4) Patients with anastomotic stoma fistula easily cause a delay in diagnosis if the leakage was wrapped in the inferior phrenic. 5) Taking preventive measures is the key method for the anastomotic aortoesophageal fistula. 6) Occurrence of pulmonary em-bolism after operation should be monitored. 7) Thoracic gastric mediastinal hernia would cause serious consequences if treatment was not taken at a proper time.
ABSTRACT
In order to develop clinical diagnostic tools for rapid detection of the SARS-CoV (severe acute respiratory syndrome-associated coronavirus) and to identify candidate proteins for vaccine development, the C-terminal portion of the nucleocapsid (NC) gene was amplified using RT-PCR from the SARS-CoV genome, cloned into a yeast expression vector (pEGH), and expressed as a glutathione S-transferase (GST) and Hisx6 double-tagged fusion protein under the control of an inducible promoter. Western analysis on the purified protein confirmed the expression and purification of the NC fusion proteins from yeast. To determine its antigenicity, the fusion protein was challenged with serum samples from SARS patients and normal controls. The NC fusion protein demonstrated high antigenicity with high specificity, and therefore, it should have great potential in designing clinical diagnostic tools and provide useful information for vaccine development.
Subject(s)
Humans , Antigens, Viral , Allergy and Immunology , Cloning, Molecular , Enzyme-Linked Immunosorbent Assay , Genetic Vectors , Genome, Viral , Nucleocapsid Proteins , Genetics , Allergy and Immunology , Recombinant Fusion Proteins , Genetics , Metabolism , Severe acute respiratory syndrome-related coronavirus , Genetics , Allergy and Immunology , Yeasts , GeneticsABSTRACT
Objective To investigate the expression of Skp2 and C-myc in hepatocellular carcinoma and its relationship with clinicopathologic characteristics.Methods The expression of skp2 and C-myc was evaluated in hepatocellular carcinoma tissues of 48 patients,liver cirrhosis tissues of 20 cases,and normal liver tissues of 16 patients by immunohistochemistry(PV9000 two steps methods).Results The expression rate of skp2(33.3%) in hepatocellular carcinoma tissues was significantly higher than that in liver cirrhosis tissues((negative) expression)(P=0.008)and normal liver tissues(negative expression)(P=0.020).The(expression) of skp2 was correlated with histological differentiation and metastasis(P﹤0.001 and P=(0.017)),but not with tumour size(P=0.058),and it was not expressed in highly differentiated(hepatocellular) carcinomas.The expression rate of C-myc protein in hepatocellular carcinoma tissues((58.3)%) was significantly higher than that in liver cirrhosis tissues(15%)(P=0.001) and normal tissues((negativ)e expression)(P